Mycord Blood Banking


MyCord Blood Banking Citation

1. Parikh SH, Kurtzberg J. Chapter 36- Umbilical Cord Blood:

A Reliable Source of Stem and Progenitor Cells for Human Transplantation. Rossi’s Principles of Transfusion Medicine. 4th Ed. West Sussex (UK):Blackwell Publishing Ltd.; 2009. p.559-65.

2. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation:

the first 25 years and beyond. Blood 2013 Jul;122(4);491-8.

3. McKenna D, Sheth J. Umbilical cord blood:

Current status & promise for the future. Indian J Med Res 2011 Sep; 134: 261-9.

4. Takiar R, Nadayil D, Nandakumar A. Projections of Number of Cancer Cases in India (2010-2020) by Cancer Groups. Asian Pacific J Cancer Prev;11:1045-9.

5. Chandy M. Stem cell transplantation in India. Bone Marrow Transplantation 2008;42:S81-4.

6. Bangalore Medical Services Trust/Rotary Bangalore TTK Blood Bank/Stem Cell Registry.

7.Source NYBC

8. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, T Demirer,GDini, H Einsele, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders:

definitions and current practice in Europe. Bone Marrow Transpl 2006;37:439–49

9. Fisk NM, Roberts IAG, Markwald R, Mironov V. Can Routine Commercial Cord Blood Banking Be Scientifically and Ethically Justified? PLoS Med 2005; 2(2):e44. doi:

10.1371/journal.pmed.0020044 10. Rosenthal J, Woolfrey AE, Pawlowska A, Thomas SH, Appelbaum F, Forman S. Hematopoietic Cell Transplantation With Autologous Cord Blood in Patients With Severe Aplastic Anemia:

An Opportunity to Revisit the Controversy Regarding Cord Blood Banking for Private Use. Pediatr Blood Cancer 2011;56:1009–12.

11. Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, et al. Factors Associated With Outcome After Cord Blood Transplantation in Children With Acute Leukemia. Blood 1999: 93:3662-71. 12. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265-75. 13. Tomblyn MB, Arora M, Baker KS, Blazar BR, Brunstein CG, Burns LJ, et al. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia:

analysis of graft sources and long-term outcome. J Clin Oncol 2009; 27: 3634-41.

14. Marks DI, Woo KA, Zhong X, Appelbaum FR, Bachanova V, Barker JN, et al. Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission:

a comparison with allografts from adult unrelated donors. Haematologica 2014;99(2):322-8.

15. Ooi J, Iseki T, Ito K, Mori Y, Sato H, Takahashi T, et al. Successful unrelated cord blood transplantation for relapse after autologous transplantation in non-Hodgkin’s lymphoma. Leuk Lymphoma. 2002 Mar;43(3):653-5. 16. Thompson PA, Perera T, Marin D, Oran B, Popat U, Qazilbash M, et al. Double umbilical cord blood transplant is effective therapy for relapsed or refractory hodgkins lymphoma. Leuk lymphoma 2015; 23:1-9. 17. Hale GA. Autologous hematopoietic stem cell transplantation for pediatric solid tumors. Expert Rev Anticancer Ther. 2005 Oct;5(5):835-46. 18. Robin M, Giannotti F, Deconinck E, Mohty M, Michallet M, Sanz G, et al. Unrelated Cord Blood Transplantation for Patients with Primary or Secondary Myelofibrosis. Biol Blood Marrow Transplant 2014; 20: 1841-68. 19. Takagi S, Ota Y, Uchida N, Takahashi K, Ishiwata K, Tsuji M, et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis. Blood 2010 Jul 29;116(4):649-52. 20. Myers KC, Davies SM. Hematopoietic Stem Cell Transplantation for Bone Marrow Failure Syndromes in Children. Biol Blood Marrow Transplant Mar 2009; 15,(3):279–92. 21. Bizzetto R, Bonfim C, Rocha V, Socié G, Locatelli F, Chan K, et al. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica. 2011 Jan;96(1):134-41. 22. Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatiya M, Kurtzberg J et al. Umbilical Cord Blood Transplantation for Children with Thalassemia and Sickle Cell Disease. American society for Blood and Marrow Transplantation, 2011:17:1375-82. 23. Jaing T-H, Tan P, Rosenthal J, Wang B, Gjertson D, Petz LD, et al. 13:

Unrelated Cord Blood Transplantation (CBT) for Hemoglobinopathy. Biol Blood Marrow Transplant 2006 Nov; 12(11):1222–3.

24. Heredia CD, Ortega JJ, Diaz MA, Olive T, Badell I, Gonzalez-Vicent M et al. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone marrow Transplantation 2008;41:627-633. 25. Knutsen AP, Wall DA. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders:

two-year experience. J ClinImmunol 2000; 20:466-76.

26. Knutsen AP, Steffen M, Wassmer K, Wall DA. Umbilical cord blood transplantation in Wiskott Aldrich syndrome. Journal of Pediatrics. 2003:142:519-23. 27. Kaneko M, Watanabe T, Watanabe H et al. Successful Unrelated Cord Blood Transplantation in an Infant with Wiskott- Aldrich Syndrome following Recurrent Cytomegalovirus Disease. International Journal of Hematology. 2003: 78:457. 28. Kato S, Yabe H, Takakura H, Mugishima H, Ishige M, Tanaka A, et al. Hematopoietic stem cell transplantation for inborn errors of metabolism:

A report from the Research Committee on Transplantation for Inborn Errors of Metabolism of the Japanese Ministry of Health, Labour and Welfare and the Working Group of the Japan Society for Hematopoietic Cell Transplantation. Pediatr Transplant. 2016 Mar;20(2):203-14.

29. Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center:

influence of cellular composition of the graft on transplantation outcomes. Blood. 2008; 112 : 2979-89.

30. Escolar ML, Michele DP, Provenzale JM, Richards KC, Allison J, Wood S et al. Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe’s Disease. The New England Journal of Medicine. 2005:352:2069-2081.

31. Staba LS, Escolar M, Poe M et al. Cord-Blood Transplants from Unrelated Donors in Patients with Hurler’s Syndrome. The New England Journal of Medicine. 2004:350:1960-1969.

32. Boelens JJ, Rocha V, Aldenhoven M, Wynn R, O’Meara A, Michel G, et al. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome. Biol Blood Marrow Transplant. 2009 May;15(5):618-25.

33Hematopoietic Stem-Cell Transplantation for Primary Amyloidosis.

34. Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood 2002 Jun; 99(12):4276-82.

36. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002;100(7):2374–86.

37. World Marrow Donor Association International Standards for Unrelated Hematopoietic Progenitor Cell Donor Registries

38. US-FDA:

Guidance for Industry. Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications, 2009.

39. Source:

Marrow Donor Program Belgium Registry.

Mycord Brochure




Mycord Presentation

2017-07-01 (1)

Still Have Questions?


Need answers? We are here to help. Our Cord Blood Educators will be with you every step of the way.

CALL NOW 1800 103 3001


Order a free information packet now and see how easy it is to protect your loved ones.